Nanoparticle: Drug delivery system for cancer therapy

Article Sidebar

PDF
Published: Aug 25, 2014
DOI: https://doi.org/10.22377/ajp.v2i3.183

Main Article Content

Nisha Mary Joseph
Pramod Kumar Sharma

Abstract

Nanoparticle has emerged as a promising strategy for the efficient delivery of drugs used in the treatment of cancer by avoiding the reticuloendothelial system, utilizing the enhanced permeability and retention effect and tumor-specific
targeting. Delivery methods using nanoparticle are highlighted including both degradable and non-degradable polymers. The preparation techniques include emulsion polymerization, micelle polymerization, desolvation of macromolecule, and
emulsion-solvent evaporation methods.The particle size of the polymeric nanoparticle is in the nanometer range (10-1000 nm) and is dependent on the method of preparation employed.

Downloads

Download data is not yet available.

Article Details

How to Cite
Joseph, N. M., & Sharma, P. K. (2014). Nanoparticle: Drug delivery system for cancer therapy. Asian Journal of Pharmaceutics (AJP), 2(3). https://doi.org/10.22377/ajp.v2i3.183
Issue
Vol. 2 No. 3 (2008): Jul-Sep
Section
Articles

This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.

References

Serpe L. Nano tectonologies for life science, Nano materials for cancer

therapy. In: Challs SS, Kumar, editors. p. 1-39.

Krecter J. Colloidal drug delivery system. New York: Dekker; 1994.

p. 219-343.

Couvvreur P, Voutheir C, DeBoer AG. Drug absorption enhancement,

concepts, possibilities, limitation and trends. Chur, Switzerland:

Hardwood Academic Publishers; 1994. p. 535-75.

Leroux JC, Deolker E, Gurmy R, Nenita S. Micro-encapsulations, Methods

and Industrial Application. New York: Dekker; 1996. p. 537-74.

Shenoy VS, Vilay IK, Murthy RS. Tumour targeting: biological factors

and formulation advances in injectable lipid nanoparticles. J Pharm

Pharmacol 2005;57:411-22.

Wang Y, Satoid, Dachi I, Hortikoshi I. Chemical and Pharmaceutical

Bulletin; 1936, 1940. p. 12996, 44.

Feng S, Huang G. Effects of emulsifiers on the controlled release

of paclitaxel (Taxol) from nanospheres of biodegradable polymers.

J Control Release 2001;71:53-69.

Fonsece C, Simoes S, Gaspar RE. Paclitaxel-loaded PLGA nanoparticles:

Preparation, physicochemical characterization and in vitro anti-tumoral

activity. J Control Release 2002;83:273-86.

Park TG, Yoo HS. Polymer Preparation. Polymer Parameters 2002;41:

-3.

Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate

carrier of fluorouracil. Int J Pharma 2003;257:111-24.